Debra Yager
Impact in
- Physiology top 0.2%
- Alzheimer's disease research and treatments
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Physiology 16
- Alzheimer's disease research and treatments 16
-
- Prion Diseases and Protein Misfolding 4
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- John Hardy (4 shared papers)Chris Eckman (3 shared papers)Mike Hutton (2 shared papers)Christopher B. Eckman (13 shared papers)Jordi Pérez‐Tur (3 shared papers)Dennis W. Dickson (2 shared papers)Shu‐Hui Yen (1 shared paper)Lisa Skipper (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)ACS Chemical Neuroscience (1 paper)Neurobiology of Disease (1 paper)Human Molecular Genetics (1 paper)Neurology (1 paper)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Debra Yager
18 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Physiology 3.9k
- Neurology 609
- Biological Psychiatry 183
- Pharmacology 1.2k
- Cellular and Molecular Neuroscience 1.2k
Countries citing papers authored by Debra Yager
This map shows the geographic impact of Debra Yager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Yager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Yager more than expected).
Fields of papers citing papers by Debra Yager
This network shows the impact of papers produced by Debra Yager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Yager. The network helps show where Debra Yager may publish in the future.
Co-authors
The 25 scholars most cited alongside Debra Yager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo Hit paper breakdown → | 1996 | 1224 |
| 2 | Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP Hit paper breakdown → | 2001 | 1203 |
| 3 | Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 Hit paper breakdown → | 1996 | 1176 |
| 4 | 2004 | 230 | |
| 5 | 1997 | 168 | |
| 6 | 1998 | 115 | |
| 7 | 1998 | 82 | |
| 8 | 1997 | 71 | |
| 9 | 2007 | 70 | |
| 10 | 2001 | 58 | |
| 11 | 2012 | 51 | |
| 12 | 2000 | 49 | |
| 13 | 1999 | 45 | |
| 14 | 2001 | 35 | |
| 15 | 2001 | 27 | |
| 16 | 2009 | 19 | |
| 17 | 2002 | 13 | |
| 18 | 1996 | 3 |
About Debra Yager
Debra Yager is a scholar working on Physiology, Molecular Biology, Computational Theory and Mathematics, Pharmacology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 4.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (16 papers), Computational Drug Discovery Methods (7 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Prion Diseases and Protein Misfolding (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Nuclear Receptors and Signaling (2 papers), Dementia and Cognitive Impairment Research (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Physiology (3.9k citations), Neurology (609 citations), Biological Psychiatry (183 citations), Pharmacology (1.2k citations) and Cellular and Molecular Neuroscience (1.2k citations). Debra Yager has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include John Hardy, Chris Eckman, Mike Hutton, Christopher B. Eckman, Jordi Pérez‐Tur, Dennis W. Dickson, Shu‐Hui Yen, Lisa Skipper, Graham L. Jones and Naruhiko Sahara. Their work appears in journals such as Journal of Biological Chemistry, ACS Chemical Neuroscience, Neurobiology of Disease, Human Molecular Genetics and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.